Home > Press > Implantable ‘living pharmacy’ could control body’s sleep/wake cycles: Project receives DARPA contract worth up to $33 million over 4 1/2 years
In this artistic illustration, a user with an NTRAIN implant and its accompanying external hub works in the field. The user inputs a desired time shift (due to shift work or travel across time zones). Based on cues from the bodys physiology, the external hub detects the users circadian rhythm, and triggers the implant to produce precisely-dosed peptide therapies. |
Abstract:
Device will harness the same peptides the body makes to regulate sleep cycles
Researchers aim to halve the time it takes to recover from disrupted sleep/wake cycles, including from jetlag and shift work
Device could be a powerful tool for military personnel and shift workers, including first responders
Implantable ‘living pharmacy’ could control body’s sleep/wake cycles: Project receives DARPA contract worth up to $33 million over 4 1/2 years
Evanston, IL | Posted on May 13th, 2021
A Northwestern University-led team of researchers has signed a cooperative agreement with the Defense Advanced Research Projects Agency (DARPA) to develop a wireless, fully implantable device that will control the bodys circadian clock, halving the time it takes to recover from disrupted sleep/wake cycles.
The first phase of the highly interdisciplinary program will focus on developing the implant. The second phase, contingent on the first, will validate the device. If that milestone is met, then researchers will test the device in human trials, as part of the third phase. The full funding corresponds to $33 million over 4 1/2 years.
Nicknamed the living pharmacy, the device could be a powerful tool for military personnel, who frequently travel across multiple time zones, and shift workers including first responders, who vacillate between overnight and daytime shifts.
Called NTRAIN (Normalizing Timing of Rhythms Across Internal Networks of Circadian Clocks), the project is a part the Advanced Acclimation and Protection Tool for Environmental Readiness (ADAPTER) program, DARPAs new program to help address the challenges of travel, including jetlag, fatigue and gastrointestinal issues. Circadian clock research will be led by sleep experts at Northwesterns Center for Sleep and Circadian Biology (CSCB). Synthetic biologists at Rice University will lead cellular engineering efforts. And Northwestern engineers will join researchers from Rice and Carnegie Mellon universities and Blackrock Microsystems to develop bioelectronic components.
Combining synthetic biology with bioelectronics, the team will engineer cells to produce the same peptides that the body makes to regulate sleep cycles, precisely adjusting timing and dose with bioelectronic controls. When the engineered cells are exposed to light, they will generate precisely dosed peptide therapies.
This control system allows us to deliver a peptide of interest on demand, directly into the bloodstream, said Northwesterns Jonathan Rivnay, principal investigator of the project. No need to carry drugs, no need to inject therapeutics and depending on how long we can make the device last no need to refill the device. Its like an implantable pharmacy on a chip that never runs out.
Rivnay is an assistant professor of biomedical engineering in Northwesterns McCormick School of Engineering. Other Northwestern members of the interdisciplinary team are professors Fred W. Turek, Martha Hotz Vitaterna, Josiah Hester, Guillermo Ameer, Peng Jiang and Phyllis C. Zee representing Weinberg College of Arts and Sciences, McCormick and Feinberg School of Medicine.
Beyond controlling circadian rhythms, the researchers believe this technology could be modified to release other types of therapies with precise timing and dosing for potentially treating pain and disease. The DARPA program also will help researchers better understand sleep/wake cycles in general.
The experiments carried out in these studies will enable new insights into how internal circadian organization is maintained, said Turek, who co-leads the sleep team with Vitaterna. These insights will lead to new therapeutic approaches for sleep disorders as well as many other physiological and mental disorders, including those associated with aging where there is often a spontaneous breakdown in temporal organization.
Members from other institutions include Doug Weber, Tzahi Cohen-Karni, Darcy Griffin, Carl Olson and Matt Smith at Carnegie Mellon; Karrie Fitzpatrick of the University of Minnesota; Omid Veiseh, Jacob Robinson, Isaac Hilton, Kaiyuan Yang and Caleb Kemere of Rice University; Florian Solzbacher of the University of Utah; and Rob Franklin of Blackrock Microsystems.
####
For more information, please click here
Contacts:
Amanda Morris
217.417.4846 (M)
Copyright © Northwestern University
If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
News and information
Nanophotonics enhanced coverslip for phase imaging in biology May 14th, 2021
New technology enables rapid sequencing of entire genomes of plant pathogens May 14th, 2021
Harvesting light like nature does:Synthesizing a new class of bio-inspired, light-capturing nanomaterials May 14th, 2021
Govt.-Legislation/Regulation/Funding/Policy
Nanophotonics enhanced coverslip for phase imaging in biology May 14th, 2021
New technology enables rapid sequencing of entire genomes of plant pathogens May 14th, 2021
Harvesting light like nature does:Synthesizing a new class of bio-inspired, light-capturing nanomaterials May 14th, 2021
Possible Futures
Emergence of a new heteronanostructure library May 14th, 2021
New technology enables rapid sequencing of entire genomes of plant pathogens May 14th, 2021
Harvesting light like nature does:Synthesizing a new class of bio-inspired, light-capturing nanomaterials May 14th, 2021
You’re so vein: Scientists discover faster way to manufacture vascular materials May 14th, 2021
Nanomedicine
Tiny, Wireless, Injectable Chips Use Ultrasound to Monitor Body Processes May 12th, 2021
World’s first fiber-optic ultrasonic imaging probe for future nanoscale disease diagnostics April 30th, 2021
Arrowhead Announces Improvement in Fibrosis after ARO-AAT Treatment in Patients with Alpha-1 Liver Disease April 28th, 2021
Announcements
Emergence of a new heteronanostructure library May 14th, 2021
Nanophotonics enhanced coverslip for phase imaging in biology May 14th, 2021
New technology enables rapid sequencing of entire genomes of plant pathogens May 14th, 2021
Harvesting light like nature does:Synthesizing a new class of bio-inspired, light-capturing nanomaterials May 14th, 2021
Military
Simple robots, smart algorithms April 30th, 2021
With new optical device, engineers can fine tune the color of light April 23rd, 2021
Silver ions hurry up, then wait as they disperse: Rice chemists show ions staged release from gold-silver nanoparticles could be useful property April 23rd, 2021
Nanobiotechnology
Tiny, Wireless, Injectable Chips Use Ultrasound to Monitor Body Processes May 12th, 2021
Arrowhead Announces Improvement in Fibrosis after ARO-AAT Treatment in Patients with Alpha-1 Liver Disease April 28th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Research partnerships
Nanophotonics enhanced coverslip for phase imaging in biology May 14th, 2021
Graphene key for novel hardware security May 10th, 2021
Silver ions hurry up, then wait as they disperse: Rice chemists show ions staged release from gold-silver nanoparticles could be useful property April 23rd, 2021
TPU scientists offer new plasmon energy-based method to remove CO2 from atmosphere March 19th, 2021